Skip to main content
Erschienen in: Cancer Causes & Control 2/2018

27.12.2017 | Original paper

Rural–urban differences in surgical treatment, regional lymph node examination, and survival in endometrial cancer patients

verfasst von: Whitney E. Zahnd, Katherine S. Hyon, Paula Diaz-Sylvester, Sonya R. Izadi, Graham A. Colditz, Laurent Brard

Erschienen in: Cancer Causes & Control | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Endometrial cancer (EC) is the most common gynecological malignancy and one of few cancers with an increasing US mortality rate. Rural patients may have less access to specialty care affecting their receipt of surgery and adequate lymphadenectomy (AL). We sought to assess rural–urban differences in EC surgery, lymphadenectomy, and survival.

Methods

We analyzed data from the Surveillance Epidemiology and End Results database on EC patients (2004–2013). We performed univariate analyses to compare rural and urban patients on demographic and clinical characteristics and receipt of nodal examination and AL. We assessed rural–urban differences in trends of receipt of AL, performed logistic regression to evaluate differences in receipt of surgery, nodal examination, and AL, and performed survival analysis.

Results

Rural patients were less likely to have any lymph nodes removed, had a smaller median number removed, and a smaller proportion had AL. Even after controlling for established risk factors, rural patients had lower odds of lymph node examination and adequate AL than urban patients and also had poorer survival.

Conclusions

Future research should continue to assess the association between access to care and disparities in surgical care and the effect of these disparities on survival.
Literatur
1.
Zurück zum Zitat American Cancer Society (2017) Cancer Facts & Figures 2017. American Cancer Society, Atlanta American Cancer Society (2017) Cancer Facts & Figures 2017. American Cancer Society, Atlanta
3.
Zurück zum Zitat Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN, Mariani A, Dowdy SC (2008) Current issues in the management of endometrial cancer. Mayo Clin Proc 83:97–112CrossRefPubMed Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN, Mariani A, Dowdy SC (2008) Current issues in the management of endometrial cancer. Mayo Clin Proc 83:97–112CrossRefPubMed
4.
Zurück zum Zitat Burke WM, Orr J, Leitao M et al (2014) Endometrial cancer: a review and current management strategies: part I. Gynecol Oncol 134:385–392CrossRefPubMed Burke WM, Orr J, Leitao M et al (2014) Endometrial cancer: a review and current management strategies: part I. Gynecol Oncol 134:385–392CrossRefPubMed
5.
Zurück zum Zitat Doll A, Abal M, Rigau M et al (2008) Novel molecular profiles of endometrial cancer-new light through old windows. J Steroid Biochem Mol Biol 108:221–229CrossRefPubMed Doll A, Abal M, Rigau M et al (2008) Novel molecular profiles of endometrial cancer-new light through old windows. J Steroid Biochem Mol Biol 108:221–229CrossRefPubMed
6.
Zurück zum Zitat Felix AS, Weissfeld JL, Stone RA et al (2010) Factors associated with Type I and Type II endometrial cancer. Cancer Causes Control 21:1851–1856CrossRefPubMedPubMedCentral Felix AS, Weissfeld JL, Stone RA et al (2010) Factors associated with Type I and Type II endometrial cancer. Cancer Causes Control 21:1851–1856CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Park JY, Kim EN, Kim DY et al (2008) Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer. Gynecol Oncol 108:486–492CrossRefPubMed Park JY, Kim EN, Kim DY et al (2008) Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer. Gynecol Oncol 108:486–492CrossRefPubMed
8.
Zurück zum Zitat Bansal N, Herzog TJ, Brunner-Brown A et al (2008) The utility and cost effectiveness of preoperative computed tomography for patients with uterine malignancies. Gynecol Oncol 111:208–212CrossRefPubMed Bansal N, Herzog TJ, Brunner-Brown A et al (2008) The utility and cost effectiveness of preoperative computed tomography for patients with uterine malignancies. Gynecol Oncol 111:208–212CrossRefPubMed
9.
Zurück zum Zitat Hsieh CH, ChangChien CC, Lin H et al (2002) Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer? Gynecol Oncol 86:28–33CrossRefPubMed Hsieh CH, ChangChien CC, Lin H et al (2002) Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer? Gynecol Oncol 86:28–33CrossRefPubMed
10.
Zurück zum Zitat Soper JT, Berchuck A, Olt GJ, Soisson AP, Clarke-Pearson DL, Bast RC Jr (1990) Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma. Am J Obstet Gynecol 163:1204–1209CrossRefPubMed Soper JT, Berchuck A, Olt GJ, Soisson AP, Clarke-Pearson DL, Bast RC Jr (1990) Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma. Am J Obstet Gynecol 163:1204–1209CrossRefPubMed
11.
Zurück zum Zitat Olawaiye AB, Rauh-Hain JA, Withiam-Leitch M, Rueda B, Goodman A, del Carmen MG (2008) Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma. Gynecol Oncol 110:293–298CrossRefPubMed Olawaiye AB, Rauh-Hain JA, Withiam-Leitch M, Rueda B, Goodman A, del Carmen MG (2008) Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma. Gynecol Oncol 110:293–298CrossRefPubMed
13.
Zurück zum Zitat Kitchener HC, Trimble EL, Endometrial Cancer Working Group of the Gynecologic Cancer Intergroup (2009). Endometrial cancer state of the science meeting. Int J Gynecol Cancer 19(1): 134–140CrossRefPubMed Kitchener HC, Trimble EL, Endometrial Cancer Working Group of the Gynecologic Cancer Intergroup (2009). Endometrial cancer state of the science meeting. Int J Gynecol Cancer 19(1): 134–140CrossRefPubMed
14.
Zurück zum Zitat Sharma C, Deutsch I, Lewin SN et al (2011) Lymphadenectomy influences the utilization of adjuvant radiation treatment for endometrial cancer. Am J Obstet Gynecol 205:562.e561–562.e569CrossRef Sharma C, Deutsch I, Lewin SN et al (2011) Lymphadenectomy influences the utilization of adjuvant radiation treatment for endometrial cancer. Am J Obstet Gynecol 205:562.e561–562.e569CrossRef
15.
Zurück zum Zitat Look KY (2004) Role of lymphadenectomy in management of adenocarcinoma of the endometrium. Eur J Gynaecol Oncol 25:545–551PubMed Look KY (2004) Role of lymphadenectomy in management of adenocarcinoma of the endometrium. Eur J Gynaecol Oncol 25:545–551PubMed
16.
Zurück zum Zitat Benedetti Panici P, Basile S, Maneschi F et al (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100:1707–1716CrossRefPubMed Benedetti Panici P, Basile S, Maneschi F et al (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100:1707–1716CrossRefPubMed
17.
Zurück zum Zitat Neubauer NL, Lurain JR (2011) The role of lymphadenectomy in surgical staging of endometrial cancer. Int J Surg Oncol 2011:814649PubMedPubMedCentral Neubauer NL, Lurain JR (2011) The role of lymphadenectomy in surgical staging of endometrial cancer. Int J Surg Oncol 2011:814649PubMedPubMedCentral
19.
Zurück zum Zitat Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373:125–136CrossRefPubMed Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373:125–136CrossRefPubMed
22.
Zurück zum Zitat Fader AN, Habermann EB, Hanson KT, Lin JF, Grendys EC, Dowdy SC (2016) Disparities in treatment and survival for women with endometrial cancer: A contemporary national cancer database registry analysis. Gynecol Oncol 143:98–104CrossRefPubMed Fader AN, Habermann EB, Hanson KT, Lin JF, Grendys EC, Dowdy SC (2016) Disparities in treatment and survival for women with endometrial cancer: A contemporary national cancer database registry analysis. Gynecol Oncol 143:98–104CrossRefPubMed
23.
Zurück zum Zitat Bregar AJ, Alejandro Rauh-Hain J, Spencer R et al (2017) Disparities in receipt of care for high-grade endometrial cancer: a National Cancer Data Base analysis. Gynecol Oncol 145:114–121CrossRefPubMed Bregar AJ, Alejandro Rauh-Hain J, Spencer R et al (2017) Disparities in receipt of care for high-grade endometrial cancer: a National Cancer Data Base analysis. Gynecol Oncol 145:114–121CrossRefPubMed
24.
Zurück zum Zitat Collins Y, Holcomb K, Chapman-Davis E, Khabele D, Farley JH (2014) Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology. Gynecol Oncol 133:353–361CrossRefPubMedPubMedCentral Collins Y, Holcomb K, Chapman-Davis E, Khabele D, Farley JH (2014) Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology. Gynecol Oncol 133:353–361CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Shalowitz DI, Vinograd AM, Giuntoli RL 2nd (2015). Geographic access to gynecologic cancer care in the United States. Gynecol Oncol 138: 115–120CrossRefPubMed Shalowitz DI, Vinograd AM, Giuntoli RL 2nd (2015). Geographic access to gynecologic cancer care in the United States. Gynecol Oncol 138: 115–120CrossRefPubMed
26.
Zurück zum Zitat Tan W, Stehman FB, Carter RL (2009) Mortality rates due to gynecologic cancers in New York state by demographic factors and proximity to a Gynecologic Oncology Group member treatment center: 1979–2001. Gynecol Oncol 114:346–352CrossRefPubMed Tan W, Stehman FB, Carter RL (2009) Mortality rates due to gynecologic cancers in New York state by demographic factors and proximity to a Gynecologic Oncology Group member treatment center: 1979–2001. Gynecol Oncol 114:346–352CrossRefPubMed
27.
Zurück zum Zitat Clemons J, Zahnd WE, Nutt M, Sadowski D, Dynda D, Alanee S (2017) Impact of urologist density and county rurality on the practice of retroperitoneal lymph node dissection and cancer-specific death in patients with nonseminomatous germ cell tumors. J Adolesc Young Adult Oncol 6:83–90CrossRefPubMed Clemons J, Zahnd WE, Nutt M, Sadowski D, Dynda D, Alanee S (2017) Impact of urologist density and county rurality on the practice of retroperitoneal lymph node dissection and cancer-specific death in patients with nonseminomatous germ cell tumors. J Adolesc Young Adult Oncol 6:83–90CrossRefPubMed
28.
Zurück zum Zitat Cole AP, Dalela D, Hanske J et al (2015) Temporal trends in receipt of adequate lymphadenectomy in bladder cancer 1988 to 2010. Urol Oncol 33:504.e509–517 Cole AP, Dalela D, Hanske J et al (2015) Temporal trends in receipt of adequate lymphadenectomy in bladder cancer 1988 to 2010. Urol Oncol 33:504.e509–517
29.
Zurück zum Zitat Chow CJ, Al-Refaie WB, Abraham A et al (2015) Does patient rurality predict quality colon cancer care?: a population-based study. Dis Colon Rectum 58:415–422CrossRefPubMedPubMedCentral Chow CJ, Al-Refaie WB, Abraham A et al (2015) Does patient rurality predict quality colon cancer care?: a population-based study. Dis Colon Rectum 58:415–422CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2015 Sub (1973-2013 varying) - Linked To County Attributes - Total U.S., 1969-2014 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2016, based on the November 2015 submission Surveillance, Epidemiology, and End Results (SEER) Program (http://​www.​seer.​cancer.​gov) SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2015 Sub (1973-2013 varying) - Linked To County Attributes - Total U.S., 1969-2014 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2016, based on the November 2015 submission
32.
Zurück zum Zitat Duong LM, Wilson RJ, Ajani UA, Singh SD, Eheman CR (2011) Trends in endometrial cancer incidence rates in the United States, 1999–2006. J Womens Health (Larchmt) 20:1157–1163CrossRef Duong LM, Wilson RJ, Ajani UA, Singh SD, Eheman CR (2011) Trends in endometrial cancer incidence rates in the United States, 1999–2006. J Womens Health (Larchmt) 20:1157–1163CrossRef
33.
Zurück zum Zitat Hill HA, Eley JW, Harlan LC, Greenberg RS, Barrett RJ 2nd, Chen VW (1996). Racial differences in endometrial cancer survival: the black/white cancer survival study. Obstet Gynecol 88: 919–926CrossRefPubMed Hill HA, Eley JW, Harlan LC, Greenberg RS, Barrett RJ 2nd, Chen VW (1996). Racial differences in endometrial cancer survival: the black/white cancer survival study. Obstet Gynecol 88: 919–926CrossRefPubMed
34.
Zurück zum Zitat Rodriguez AM, Schmeler KM, Kuo YF (2014) Disparities in endometrial cancer outcomes between non-Hispanic White and Hispanic women. Gynecol Oncol 135:525–533CrossRefPubMed Rodriguez AM, Schmeler KM, Kuo YF (2014) Disparities in endometrial cancer outcomes between non-Hispanic White and Hispanic women. Gynecol Oncol 135:525–533CrossRefPubMed
35.
Zurück zum Zitat Melamed A, Rauh-Hain JA, Clemmer JT et al (2015) Changing trends in lymphadenectomy for endometrioid adenocarcinoma of the endometrium. Obstet Gynecol 126:815–822CrossRefPubMed Melamed A, Rauh-Hain JA, Clemmer JT et al (2015) Changing trends in lymphadenectomy for endometrioid adenocarcinoma of the endometrium. Obstet Gynecol 126:815–822CrossRefPubMed
36.
Zurück zum Zitat Bogani G, Dowdy SC, Cilby WA, Ghezzi F, Rossetti D, Mariani A (2015) Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence. J Obstet Gynaecol Res 40(2):301–311CrossRef Bogani G, Dowdy SC, Cilby WA, Ghezzi F, Rossetti D, Mariani A (2015) Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence. J Obstet Gynaecol Res 40(2):301–311CrossRef
38.
Zurück zum Zitat Mannschreck D, Matsuno RK, Moriarty JP et al (2016) Disparities in surgical care among women with endometrial cancer. Obstet Gynecol 128:526–534CrossRefPubMed Mannschreck D, Matsuno RK, Moriarty JP et al (2016) Disparities in surgical care among women with endometrial cancer. Obstet Gynecol 128:526–534CrossRefPubMed
39.
Zurück zum Zitat Modesitt SC, Huang B, Shelton BJ, Wyatt S (2006) Endometrial cancer in Kentucky: the impact of age, smoking status, and rural residence. Gynecol Oncol 103:300–306CrossRefPubMed Modesitt SC, Huang B, Shelton BJ, Wyatt S (2006) Endometrial cancer in Kentucky: the impact of age, smoking status, and rural residence. Gynecol Oncol 103:300–306CrossRefPubMed
42.
Zurück zum Zitat ACOG Committee Opinion No. 586: Health disparities in rural women (2014). Obstet Gynecol 123:384–388 ACOG Committee Opinion No. 586: Health disparities in rural women (2014). Obstet Gynecol 123:384–388
Metadaten
Titel
Rural–urban differences in surgical treatment, regional lymph node examination, and survival in endometrial cancer patients
verfasst von
Whitney E. Zahnd
Katherine S. Hyon
Paula Diaz-Sylvester
Sonya R. Izadi
Graham A. Colditz
Laurent Brard
Publikationsdatum
27.12.2017
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 2/2018
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-017-0998-4

Weitere Artikel der Ausgabe 2/2018

Cancer Causes & Control 2/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.